Clinical Trial Update: Induction Chemotherapy of TPX in Nomogram-predicted High Risk Locoregionally Advanced Nasopharyngeal Carcinoma [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating induction chemotherapy with TPX for nomogram-predicted high-risk locoregionally advanced nasopharyngeal carcinoma; the cu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Snippet

Sponsor: Sun Yat-sen University | Conditions: Nasopharyngeal Carcinoma | Phase 3 | Status: UNKNOWN